Published in N Engl J Med on December 18, 1975
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1983) 1.75
The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48
Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest (1985) 1.28
Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer (1983) 1.19
Use of non-steroidal anti-inflammatory drugs in the treatment of pain in cancer. Br J Clin Pharmacol (1980) 1.12
Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer. Proc R Soc Med (1977) 1.06
Prostaglandins, thromboxanes and leukotrienes in clinical medicine. West J Med (1985) 1.02
Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer (1977) 0.96
Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin. Biochemistry (2009) 0.92
Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects. Am J Pathol (1977) 0.91
Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells. J Clin Invest (1986) 0.89
Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy. J Clin Pathol (1978) 0.86
Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits. Br J Cancer (1979) 0.86
Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br J Cancer (1980) 0.85
Medical management of hypercalcaemia. Br J Clin Pharmacol (1992) 0.84
Hypercalcaemia and in vitro osteolysis associated with xenografts of squamous carcinomas of the tongue. Br J Cancer (1983) 0.84
Breast cancer, prostaglandins and patient survival. Br J Cancer (1989) 0.84
Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia. Proc Natl Acad Sci U S A (1982) 0.83
Hypercalcemia and cancer: an update. Can Med Assoc J (1978) 0.82
Paraneoplastic syndromes. West J Med (1980) 0.82
Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma. ISRN Oncol (2013) 0.81
Ultrastructural evaluation of adenocarcinomas derived from apocrine glands of the anal sac associated with hypercalcemia in dogs. Am J Pathol (1982) 0.80
Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma. J Exp Med (1978) 0.80
Incidence and pathophysiology of hypercalcemia. Calcif Tissue Int (1990) 0.79
Role of prostaglandins in bone metabolism: a review. J R Soc Med (1979) 0.78
The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med (1978) 0.78
Serum parathyroid hormone levels in the hypercalcaemia of urological malignant disease. J R Soc Med (1986) 0.77
Bone Density in Patients with Cervical Cancer or Endometrial Cancer in comparison with Healthy Control; According to the stages. J Cancer (2015) 0.75
Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth. J Exp Med (1986) 0.75
Changes in bone density after cancer treatment in patients with cervical and endometrial cancer. J Cancer (2015) 0.75
Fatigue, weakness, anemia and hypercalcemia in a 63-year-old woman. Can Med Assoc J (1981) 0.75
Treatment of hypercalcaemia in sarcoidosis with flurbiprofen. Br Med J (Clin Res Ed) (1983) 0.75
Malignant hypercalcaemia and leucocytosis associated with carcinoma of the bronchus. Thorax (1983) 0.75
Studies on the pathogenesis of cancer hypercalcemia. Trans Am Clin Climatol Assoc (1977) 0.75
Animal model of human disease. Pseudohyperparathyroidism. Animal model: Hypercalcemia associated with lymphosarcoma (pseudohyperparathyroidism) in dogs. Am J Pathol (1977) 0.75
Intratubular calcium phosphate deposition in acute analgesic nephropathy in rabbits. Am J Pathol (1982) 0.75
Lymphosarcoma with hypercalcemia and osteolysis in a dog. Can Vet J (1983) 0.75
Hypercalcemia of malignancy: Hypercalcemia associated with an adenocarcinoma of the apocrine glands of the anal sac. Am J Pathol (1982) 0.75
Editorial: Ectopic secretion by tumours. Br Med J (1976) 0.75
Basic isoferritin and hypercalcaemia in renal cell carcinoma. J Clin Pathol (1982) 0.75
Calcium metabolism in breast cancer. Proc R Soc Med (1977) 0.75
Criteria for development of animal models of diseases of the endocrine system. Am J Pathol (1980) 0.75
Prevention and treatment of bone fragility in cancer patient. Clin Cases Miner Bone Metab (2015) 0.75
The management of severe hypercalcaemia. Postgrad Med J (1987) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science (1996) 8.14
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science (1991) 4.00
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. Proc Natl Acad Sci U S A (1963) 3.31
Pre-proparathyroid hormone: a direct translation product of parathyroid messenger RNA. Proc Natl Acad Sci U S A (1974) 3.24
Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol (2001) 3.13
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science (1980) 3.06
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A (1992) 3.01
Cloning and nucleotide sequence of DNA coding for bovine preproparathyroid hormone. Proc Natl Acad Sci U S A (1979) 2.72
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod (2002) 2.55
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem (1987) 2.38
Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone. Proc Natl Acad Sci U S A (1981) 2.36
Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology (1968) 2.36
Nucleotide sequence of the human parathyroid hormone gene. Proc Natl Acad Sci U S A (1983) 2.35
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J (1980) 2.29
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Pre-proparathyroid hormone: analysis of radioactive tryptic peptides and amino acid sequence. Biochemistry (1976) 2.25
Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology (1995) 2.25
A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab (1974) 2.20
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
Abdominal trauma in primary blast injury. Br J Surg (2011) 2.11
Pre-proparathyroid hormone; amino acid sequence, chemical synthesis, and some biological studies of the precursor region. Proc Natl Acad Sci U S A (1978) 2.07
Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A (1971) 2.04
The Department of Military Medicine--a graduate medical education idea whose time has come. Mil Med (1989) 2.04
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab (1967) 2.00
Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med (1973) 1.99
Proparathyroid hormone: identification of a biosynthetic precursor to parathyroid hormone. Proc Natl Acad Sci U S A (1972) 1.97
Phonotactic and prosodic effects on word segmentation in infants. Cogn Psychol (1999) 1.96
Isolation and chemical properties of porcine parathyroid hormone. Biochemistry (1971) 1.92
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia. Clin Chem (1992) 1.86
Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology (1996) 1.86
Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics (1999) 1.83
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. J Clin Invest (1972) 1.77
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Parathyroid hormone: chemical properties and structural requirements for biological and immunological activity. Recent Prog Horm Res (1966) 1.74
Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol (2001) 1.73
Evaluation by radioimmunoassay of factors controlling the secretion of parathyroid hormone. Nature (1966) 1.71
Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med (1982) 1.71
Assessment of damage to I-131-labeled parathyroid hormone by chromatoelectrophoresis and adsorption onto dextran-charcoal. J Lab Clin Med (1970) 1.70
The spectrum of bone disease in end-stage renal failure--an evolving disorder. Kidney Int (1993) 1.68
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
Pre-proparathyroid hormone. Evidence for an early biosynthetic precursor of proparathyroid hormone. J Biol Chem (1976) 1.67
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology (1973) 1.65
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Optimal antibiotic therapy in cholera. Bull World Health Organ (1968) 1.58
Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr (1992) 1.58
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res (1986) 1.54
Parathyroid hormone: sequence, synthesis, immunoassay studies. Am J Med (1971) 1.53
Role of CT and MR imaging in the management of tuberculous spondylitis. Radiol Clin North Am (1995) 1.52
Structural analysis of human proparathyroid hormone by a new microsequencing approach. Nature (1974) 1.50
Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci U S A (1971) 1.50
Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate. Toxicon (1972) 1.49
Structural packaging in the input to language learning: contributions of prosodic and morphological marking of phrases to the acquisition of language. Cogn Psychol (1987) 1.48
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47
Proparathyroid hormone: biosynthesis by human parathyroid adenomas. Science (1972) 1.47
Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab (1988) 1.46
Gene encoding parathyroid hormone. Nucleotide sequence of the rat gene and deduced amino acid sequence of rat preproparathyroid hormone. J Biol Chem (1984) 1.45
Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol (1997) 1.45
Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43
Calcitonin messenger RNA encodes multiple polypeptides in a single precursor. Science (1981) 1.43
Hypertension and fibromuscular dysplasia of the renal arteries. Surgery (1969) 1.42
Biosynthesis of parathyroid hormone (second of two parts). N Engl J Med (1978) 1.42
Radioimmunoassay for substance P. Nat New Biol (1973) 1.41
Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther (1968) 1.40
Synthetic pre-proparathyroid hormone leader sequence inhibits cell-free processing of placental, parathyroid, and pituitary prehormones. J Biol Chem (1980) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Probable gallbladder infection in convalescent cholera patients. Lancet (1967) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Validation of two-dimensional models for estimation of portion size in nutrition research. J Am Diet Assoc (1992) 1.39
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Calcium-dependent intracellular degradation of parathyroid hormone: a possible mechanism for the regulation of hormone stores. Endocrinology (1975) 1.37
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology (1993) 1.37